The use of serum fructosamine in diabetes detection was investigated during a diabetes survey performed with a modified oral glucose tolerance test (MOGTT) on 742 residents of the Melton Mowbray area aged between 65 and 85 years. Subjects were tested in the morning and remained at rest. MOGTT results were classified by W H O criteria. The fructosamine concentration was measured in a random sub-group of 264 normal subjects and had a Gaussian distribution (mean = 1.67 mmol/L, SD = 0.126 mmol/L). In the survey as a whole 25 new diabetics were found of which 23 had fructosamine measured; 17 had values above the 95th percentile and four more had values above the 90th percentile. We have found fructosamine concentration to be a useful screen for diabetes but this may be dependent upon the standardized sampling procedure used, and the population studied.
SUMMARY. The use of serum fructosamine in diabetes detection was investigated during a diabetes survey performed with a modified oral glucose tolerance test (MOGTT) on 742 residents of the Melton Mowbray area aged between 65 and 85 years. Subjects were tested in the morning and remained at rest. MOGTT results were classified by W H O criteria. The fructosamine concentration was measured in a random sub-group of 264 normal subjects and had a Gaussian distribution (mean = 1.67 mmol/L, SD = 0.126 mmol/L). In the survey as a whole 25 new diabetics were found of which 23 had fructosamine measured; 17 had values above the 95th percentile and four more had values above the 90th percentile. We have found fructosamine concentration to be a useful screen for diabetes but this may be dependent upon the standardized sampling procedure used, and the population studied.
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Diabetes is defined biochemically by the blood glucose concentration, often in response to a glucose load.' Diabetes is common in the elderly, but type 2 diabetes may be asymptomatic in these subjects and it has long been realized that screening for diabetes is worthwhile.2 However, even a modified oral glucose tolerance test (MOGTT)' is time consuming to organize. Although the fasting and random plasma glucose levels are easy to perform, they are insensitive'Jq4 compared to a glucose tolerance test.
Several population based studies have examined the use of glycosylated haemoglobin levels for this screening p~r p o s e ,~.~ but found them to be of limited value. It has been suggested that fructosamine may be better than glycosylated haemoglobin for screening,6 but another study found the glyosylated haemoglobin superior.' However, most studies investigating the use of fructosamine for screening have been marred by poor subject selection for the non-diabetic control group, and/or have not been based on the general population.6-10 One population survey omitted to screen for undiagnosed diabetic subjects."
Since fructosamine is cheap and relatively simple to measure, we investigated its use whilst screening the elderly of Melton Mowbray for The MOGTT was performed according to W H O criteria; after an overnight fast, the subjects drank 388mL of Lucozade which contains the equivalent of 75 g anhydrous glucose in the form of hydrolysed starch. The subjects rested until a venous blood sample was taken 2 h later for plasma glucose and serum albumin and fructosamine measurements. The blood samples were kept at 4 "C, separated within 4 h, and the plasma and serum frozen for later analysis.
The subjects also collected a random urine sample which was tested using BM-test-SL strips for glycosuria (Boehringer Mannheim, Sussex, UK).
Plasma glucose was measured on all subjects using the glucose oxidase method on a Beckman If the second result was 11 -1 mmol/L or more, the subject was labelled diabetic, but if less than 11.1 mmol/L the subject was labelled as having Impaired Glucose Tolerance (IGT). standardized against an aqueous solution of 1-deoxy-1-morpholinofructose which contained 40g/L human albumin. The within batch coefficient of variation (CV) was 1.2% (mean 1-69 mmol/L) and between batch CV was 2.2% (mean 1 -22 mmol/L). Serum albumin was measured in these subjects using the bromocresol green method on a Technicon SMACII analyser (Technicon Instruments, Basingstoke, UK).
RESULTS
In the survey as a whole 742 residents were tested, 25 new diabetics were found and 56 people had IGT. The serum fructosamine concentration in 264 subjects with normal glucose tolerance had a Gaussian distribution, with a mean of 1-67mmol/L and standard deviation of 0-126mmol/L. There was no sex difference in fructosamine level in normal subjects (women mean = 1.672 mmoVL, SD = 0.0130; men mean=1.664mmol/L, SD=0.122; ttestP>0.1), and age also had no effect (correlation coefficient = -0.182; deviation from nil correlation t=2.99, P > O . l ) .
The serum fructosamine concentration was measured in 23 previously undiagnosed diabetic subjects (median = 2.15 mmol/L; range = 1.6 to 3-45mmol/L) and in 48 subjects with IGT (median = 1.74 mmol/L; range = 1.4 to 2.13 mmol/L).
The percentile distribution of fructosamine concentrations in normal subjects is given in Table 1 , together with the distribution of values from the subjects with abnormal glucose tolerance; two diabetic subjects had fructosamine levels below the 70th percentile (1.60 and 1.67 mmol/L). By extrapolating from the 264 normal subjects to all 661 normal subjects, and including IGT subjects, the predictive values of the fructosamine level to distinguish from diabetic and non-diabetic subjects were calculated.
The IGT group included three subjects who had an initial MOGTT result greater than 11 .O mmol/L but were classified as IGT after second MOGTT; their fructosamine concentrations were 1.73, 1-89, 1-95 mmol/L.
All patients had albumin levels within the normal range (35-55 g/L), 13 of the 23 diabetics had glycosuria (tested with BM-test-5L strips).
DISCUSSION
These results show that using the 95th percentile (1.92 mmol/L) as a cut-off point, fructosamine achieves a sensitivity of 74% in detecting diabetic subjects and if the 90th percentile (1 -82 mmol/L) is used the sensitivity is 91%. The results from this study show a better performance than two other studieshv9 which preselected subjects, thus improving the performance of their test. Two previous studies used fructosamine in population based screening surveys; one found less sensitive results in elderly Dutch with a sensitivity of 47% at a specificity of 92%14, whereas a corresponding sensitivity of 87% was found in our study. On examining Moslem Asians in Tanzania, a sensitivity of 19% at a specificity of 99%15 was found.
Several factors improved the discriminatory power of serum fructosamine in our study. The tests were done in the morning, minimizing diurnal variation and the subjects rested during the MOGTT reducing variations in fructosamine level due to posture and activity," none of the subjects had an acute illness and all had a normal serum albumin. Although age per se does not effect glycosylation of other tissues proteins,l' our normal was defined for a specific sector of the population (elderly British Europids), which may also have helped.
In this study the diagnosis was confirmed by a repeat MOGTT reclassifying three subjects as IGT who would have been labelled as diabetic otherwise. If these three subjects are classified as diabetic, it reduces the sensitivity of the fructosamine test slightly (95th percentile sensitivity 66.7%; 90th percentile sensitivity 85%); this may be a factor in the lower sensitivity of other studies.
However, many of these discriminatory factors also applied to the study in Tanzania,15 which showed considerable overlap between normal and diabetic fructosamine values. The Tanzanian study included subjects of all age groups; the normal range was derived from half the normal subjects in each age group which would introduce a bias towards young subjects, whilst one would expect diabetes to be commoner in older subjects. Of Tanzanians tested 23% had IGT and fructosamine levels overlapped considerably with those of normal and diabetic subjects, thus reducing the predictive value of the test. However, only six of the 32 new diabetic Tanzanians had an elevated fructosamine which suggested that non-diabetic Tanzanians have higher blood glucose levels than subjects from areas with a low prevalence of glucose intolerance.
Thus we have found that the fructosamine concentration is a reasonable tool for detecting diabetes but this depends not only on the survey method, but also on the study population. It is particularly important to define the normal range for the study population since the normal upper limit for serum fructosamine level varies greatly from 1.18 mmol/L in Tanzania,I5 to 3.12 mmol/L in Kawerau." Because of the way diabetes is presently defined, fructosamine does not replace the glucose tolerance test (GTT), although some would argue that the GTT itself is not a particularly good test.18 The fructosamine level could prove useful as a simple screen for subjects at risk of being diabetic to select a sub-group in whom a GTT would be worthwhile.
